Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 10, 2004, Pages 1228-1233

  Bowerman, Ronald J ^a,b  

^a MENNONITE CHRISTIAN HOSPITAL   (Taiwan)

^b EHP 444 ^*  (Papua New Guinea)

Author keywords

BCG vaccine; RT23 tuberculin; Taiwan; Tuberculin skin test; Tuberculosis

Indexed keywords

BCG VACCINE; TUBERCULIN;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN TEST; TAIWAN; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BCG VACCINE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; SEX FACTORS; TAIWAN; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

EID: 5644269102     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fine P E. Bacille Calmette-Guerin vaccines: a rough guide. Clin Infect Dis 1995; 20: 11-14.
2. Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996; 45(RR-4): 1-16.
3. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Clin Infect Dis 1995; 21: 9-27.
4. Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996; 348: 17-24.
5. Comstock G W, O'Brien R J. Tuberculosis. In: Evans A S, Brachman P S, eds. Bacterial infections of humans, epidemiology and control. New York, NY: Plenum Medical Book Company, 1998: 777-804.
6. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142: 725-735.
7. Rumisha D, Baretedi J, Chimidza N, et al. Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage - Botswana, 1996. MMWR 1997; 46: 846-851.
8. Almeida L M, Barbieri M A, Da Paixao A C, Cuevas L E. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001; 20: 1061-1065.
9. Hoft D F, Tennant J M. Persistence and boosting of bacille Calmette-Guerin-induced delayed-type hypersensitivity. Ann Intern Med 1999; 131: 32-36.
10. Murray D L. Multiple Bacille Calmette-Guerin vaccination and interpretation of the Mantoux test in children [letter]. Clin Infect Dis 1995; 21: 1533.
11. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49(RR-6): 1-54.
12. Chee C B, Soh C H, Boudville I C, Chor S S, Wang Y T. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001; 164: 958-961.
13. Wang L, Turner M O, Elwood R K, Schulzer M, FitzGerald J M. A meta-analysis of the effect of Bacille Calmette-Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
14. Yu M C, Suo J, Huang C, Bai K J, Lin T P, Luh K T. Annual risk of tuberculosis infection in Taiwan, 1996-1998. J Formos Med Assoc 1999; 98: 496-499.
15. Taiwanese Government. The Executive Yuan. Control of Communicable Diseases. Public Health in the Republic of China (ROC). Taipei, Taiwan, China, ROC: Department of Health, 1995: 59-78.
16. Bowerman R J. Improving TB control with selected isoniazid preventive therapy in children and adolescents [letter]. Chinese (Taipei) J Public Health 1997; 16: 453-454.
17. Guillermo M, Gilman R H, Checkley W, et al. Community infection ratio as an indicator for tuberculosis control. Lancet 1995; 345: 416-419.
18. Getchell W S, Davis C E, Gilman J, Urueta G, Ruiz-Huidobro E, Gilman R H. Basic epidemiology of tuberculosis in Peru: a prevalence study of tuberculin sensitivity in Pueblo Joven. Am J Trop Med Hyg 1992; 47: 721-729.
19. Kuyucu N, Kuyucu S, Bakirtas A, Karacan C. BCG revaccination and tuberculin reactivity. Indian J Pediatr 2001; 68: 21-25.
20. Moreno S, Blazquez R, Vovoa A, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001; 161: 1760-1765.
21. Garcia-Garcia M L, Jimenez-Corona A, Jimenez-Corona M E. Factors associated with tuberculin reactivity in two general hospitals in Mexico. Infect Control Hosp 2001; 22: 88-93.
22. Waddell R D, von Reyn C F, Baboo K S, Mwinga A, Chintu C, Zumla A. The effects of BCG immunizations and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia. Int J Tuberc Lung Dis 1999; 3: 255-260.
23. Comstock G W, Edwards L B, Philip R N, et al. A comparison in the United States of America of two tuberculins, PPD-S and RT 23. Bull World Health Organ 1964; 31: 161-70.
24. Arnadottir T, Rieder H L, Trébucq A, et al. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl 1): 1-19.
25. Kuemmerer J M, Comstock G W. Sociologic concomitants of tuberculin sensitivity. Am Rev Respir Dis 1967; 96: 885-892.
26. Iseman M D. Preventive chemotherapy of tuberculosis. A clinician's guide to tuberculosis. Philadelphia, PA: Lippincott, Williams & Williams, 2000: 355-398.
27. Dean A G, Dean J A, Coulombier D, et al. Epi Info, Version 6: a word processing database, and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.